Editorial: Target organ damage in Fabry disease.
作者信息
Iaccarino Guido, Graziani Francesca
机构信息
Department of Clinical Medicine and Surgery, Federico II University, Napoli, Italy.
Department of Cardiovascular Sciences, Agostino Gemelli University Polyclinic (IRCCS), Rome, Italy.
出版信息
Front Cardiovasc Med. 2025 Jul 8;12:1651117. doi: 10.3389/fcvm.2025.1651117. eCollection 2025.
Abstract
摘要
相似文献
1
Editorial: Target organ damage in Fabry disease.
Front Cardiovasc Med. 2025 Jul 8;12:1651117. doi: 10.3389/fcvm.2025.1651117. eCollection 2025.
2
Clinical management of female patients with Fabry disease based on expert consensus.
Orphanet J Rare Dis. 2025 Jan 7;20(1):7. doi: 10.1186/s13023-024-03500-7.
3
Pathogenesis and Molecular Mechanisms of Anderson-Fabry Disease and Possible New Molecular Addressed Therapeutic Strategies.
Int J Mol Sci. 2021 Sep 18;22(18):10088. doi: 10.3390/ijms221810088.
4
Evolution of Cardiac Damage Staged With Echocardiography in Fabry Disease.
J Am Heart Assoc. 2025 Jun 3;14(11):e041627. doi: 10.1161/JAHA.124.041627. Epub 2025 May 23.
5
Oxidative Stress and Cardiovascular-Renal Damage in Fabry Disease: Is There Room for a Pathophysiological Involvement?
J Clin Med. 2018 Nov 2;7(11):409. doi: 10.3390/jcm7110409.
6
Urine-derived renal epithelial cells for deep phenotyping and transcriptomic response to therapy in Fabry disease.
Clin Sci (Lond). 2025 Jul 28;139(14):791-808. doi: 10.1042/CS20255570.
7
Genetics, cardiac phenotype and cardiovascular outcomes in Fabry disease patients in Finland.
ESC Heart Fail. 2025 Jul 21. doi: 10.1002/ehf2.15387.
8
Fabry disease: Mechanism and therapeutics strategies.
Front Pharmacol. 2022 Oct 26;13:1025740. doi: 10.3389/fphar.2022.1025740. eCollection 2022.
9
Fabry-specific treatment in Australia: time to align eligibility criteria with international best practices.
Intern Med J. 2024 Jun;54(6):882-890. doi: 10.1111/imj.16327. Epub 2024 Jan 11.
10
Cognitive dysfunction and depression in Fabry disease: a systematic review.
J Inherit Metab Dis. 2014 Mar;37(2):177-87. doi: 10.1007/s10545-013-9643-x. Epub 2013 Aug 16.
本文引用的文献
1
Fabry Disease: Cardiac Implications and Molecular Mechanisms.
Curr Heart Fail Rep. 2024 Apr;21(2):81-100. doi: 10.1007/s11897-024-00645-1. Epub 2024 Jan 30.
2
Global reach of over 20 years of experience in the patient-centered Fabry Registry: Advancement of Fabry disease expertise and dissemination of real-world evidence to the Fabry community.
Mol Genet Metab. 2023 Jul;139(3):107603. doi: 10.1016/j.ymgme.2023.107603. Epub 2023 Apr 29.
3
Challenging the traditional approach for interpreting genetic variants: Lessons from Fabry disease.
Clin Genet. 2022 Apr;101(4):390-402. doi: 10.1111/cge.14102. Epub 2021 Dec 28.
4
Lysosomal glycosphingolipid catabolism by acid ceramidase: formation of glycosphingoid bases during deficiency of glycosidases.
FEBS Lett. 2016 Mar;590(6):716-25. doi: 10.1002/1873-3468.12104. Epub 2016 Mar 3.
Zotero 插件